Amylyx Pharmaceuticals, Inc. (AMLX)
13.99
-0.39
(-2.71%)
USD |
NASDAQ |
Mar 13, 16:00
13.72
-0.27
(-1.93%)
After-Hours: 20:00
Amylyx Pharmaceuticals Shareholders Equity (Quarterly) : 305.26M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Disc Medicine, Inc. | 739.83M |
| Cytokinetics, Inc. | -659.62M |
| Ionis Pharmaceuticals, Inc. | 489.09M |
| MediciNova, Inc. | 41.59M |
| Scholar Rock Holding Corp. | 245.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 334.07M |
| Total Liabilities (Quarterly) | 28.82M |
| Debt to Equity Ratio | 0.0195 |
| Current Ratio | 14.27 |
| Net Debt Paydown Yield | -0.05% |